EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Type I IFN in Glomerular Disease: Scarring beyond the STING

Alexis Paulina Jimenez-Uribe iD, Steve Mangos iD, Eunsil Hahm

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25052497 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Alexis Paulina Jimenez-Uribe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Nephrology, Rush University Medical Center, Chicago, IL 60612, USA. Hauptthemen laut MEDLINE: Interferon Type I, Virus Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The field of nephrology has recently directed a considerable amount of attention towards the stimulator of interferon genes (STING) molecule since it appears to be a potent driver of chronic kidney disease (CKD). STING and its activator, the cyclic GMP-AMP synthase (cGAS), along with intracellular RIG-like receptors (RLRs) and toll-like receptors (TLRs), are potent inducers of type I interferon (IFN-I) expression. These cytokines have been long recognized as part of the mechanism used by the innate immune system to battle viral infections; however, their involvement in sterile inflammation remains unclear. Mounting evidence pointing to the involvement of the IFN-I pathway in sterile kidney inflammation provides potential insights into the complex interplay between the innate immune system and damage to the most sensitive segment of the nephron, the glomerulus. The STING pathway is often cited as one cause of renal disease not attributed to viral infections. Instead, this pathway can recognize and signal in response to host-derived nucleic acids, which are also recognized by RLRs and TLRs. It is still unclear, however, whether the development of renal diseases depends on subsequent IFN-I induction or other processes involved. This review aims to explore the main endogenous inducers of IFN-I in glomerular cells, to discuss what effects autocrine and paracrine signaling have on IFN-I induction, and to identify the pathways that are implicated in the development of glomerular damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Type IVirus DiseasesHumansImmunity, InnateSignal TransductionCicatrixToll-Like ReceptorsInflammation

Stichwörter der Autor:innen

IFN-I pathwaySTINGglomerular diseasesintracellular pattern-recognition receptorssterile inflammation

Substanzen

Interferon Type IToll-Like Receptors

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Nephrology, Rush University Medical Center, Chicago, IL 60612, USA.

ORCID-Profile: Alexis Paulina Jimenez-Uribe, Steve Mangos

Förderung

  • NIDDK NIH HHS
  • National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK)

Zitieren

APA

Jimenez-Uribe, A. P., Mangos, S., & Hahm, E. (2024). Type I IFN in Glomerular Disease: Scarring beyond the STING. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052497

Vancouver

Jimenez-Uribe AP, Mangos S, Hahm E. Type I IFN in Glomerular Disease: Scarring beyond the STING. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052497

BibTeX
@article{JimenezUribe2024,
  author = {Jimenez-Uribe, Alexis Paulina and Mangos, Steve and Hahm, Eunsil},
  title = {Type I IFN in Glomerular Disease: Scarring beyond the STING},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25052497}
}
Kostenlos starten →